|Dr. Edward Lee|
The purpose of the R13 grant through the NIA is to support the ADRD and aging components of conferences and scientific meetings, to better disseminate latest developments related to pathologic heterogeneity in dementia and aging. Specific to the AANP, this grant aims to enhance the education of neuropathology trainees about ADRD and aging to attract the next-generation of ADRD neuropathologists. Notably, this grant markedly expands the support available for trainees to attend the annual meeting such that 30 trainees will receive trainee travel awards this year.
This year’s 94th Annual Meeting will kick-off on Thursday, June 7 with the first half of the Special Course: Neuropathology of Aging featuring the following speakers: Elizabeth Mormino, PhD, Stanford University; John Crary, MD, PhD, Icahn School of Medicine at Mount Sinai; Peter Nelson, MD, PhD, University of Kentucky; and Julie Schneider, MD, MS, Rush University Medical Center. The DeArmond Lecture: Dysregulated Metabolism in the Pathogenesis of Alzheimer’s Disease: Type 3 Diabetes will take place on Friday featuring Suzanne de la Monte, MD, MPH, of the Warren Alpert Medical School of Brown University. In addition, multiple platform sessions throughout the meeting will focus on aging and neurodegenerative diseases including sessions on
Alzheimer’s disease, chronic traumatic encephalopathy, frontotemporal lobar degeneration, Lewy body disease and prion disease. Lastly, this year will also include the first-ever Award for Best Neurodegenerative Disease Case Presented at the 2018 Diagnostic Slide Session.
“We are thrilled to be R13 grant recipients,” said current AANP President Elizabeth Cochran, MD. “Thank you to everyone who dedicated time and focus in developing our proposal, and thank you to the National Institute on Aging for their support.”
Post a Comment